FDA recalls another blood pressure medication for possible cancer risk

EAST WINDSOR, N.J. – Another blood pressure medication has been recalled over concerns it could contain trace amounts of carcinogens.

The medication is manufactured by Aurobino Pharma USA, Inc. The recall is voluntary.

It affects 80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP.

If you take the drug, contact your doctor.

You can check out all the latest drug recalls here.

Six blood pressure medications have been recalled since November.

All have been found to have trace amounts of N-nitrosodiethylamine (NDEA) and are manufactured by different companies.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.